Home Physical Sciences Design, synthesis and pharmacological profile of (−)-verbenone hydrazones
Article Open Access

Design, synthesis and pharmacological profile of (−)-verbenone hydrazones

  • Mariia Nesterkina EMAIL logo , Dmytro Barbalat and Iryna Kravchenko
Published/Copyright: August 7, 2020

Abstract

A series of novel (−)-verbenone hydrazones was designed and synthesized via condensation of terpenoid with hydrazides derived from phenoxyacetic acid. The structure of target compounds was confirmed by 1H-NMR and 13C-NMR analysis, Raman and FT-IR spectroscopy, electrospray ionization method and fast atom bombardment (FAB) mass spectrometry. Thermal properties of (−)-verbenone hydrazones 3a3e were estimated by differential scanning calorimetry and their purity by HPLC coupled to mass spectrometry. Verbenone hydrazones were revealed to exist as Z/E geometrical isomers about C═N bond and cis/trans amide conformers. Verbenone derivatives were estimated as potential anticonvulsant agents after their oral administration against pentylenetetrazole and maximal electroshock-induced seizures in mice. Analgesic effect of hydrazones was studied by topical application on models of allyl isothiocyanate and capsaicin-induced pain. The present findings indicate that verbenone hydrazones contribute to seizure protection both at short (6 h) and long (24 h) time periods by blocking chemical- and electroshock-induced convulsions. Binding of compounds 3a3e to TRPA1/TRPV1 ion channels was suggested as a feasible mechanism explaining their significant analgesic activity.

1 Introduction

Essential oils as well as their individual constituents possess both significant analgesic activity and effect on central nervous system-related disorders [1]. The results of investigation revealed the pronounced pain relief action of essential oils isolated from Rosmarinus officinalis and Verbena officinalis containing the dominant component bicyclic monoterpene verbenone [2,3,4]. Among other findings, a rodent study demonstrated the anticonvulsant activity of verbenone due to direct or indirect impact on the GABAergic system [5]. Moreover, terpenes were found to improve the delivery of drugs through the skin by co-administration with pharmaceutical compounds or through the use of microemulsions for the transdermal absorption of drugs [1,6]. Terpenes and terpenoids may also serve as a transmembrane carrier via their conjugation with hydrophilic compounds [7]. Consequently, terpenoids are unique scaffold that might be used for further chemical modification aimed at synthesizing the compounds simultaneously affecting the central and peripheral nervous systems.

In this context, substantial attention is concentrated on hydrazones comprising their structure azomethine group ‒NH‒N═C‒ and undergoing hydrolytic reactions both in vitro and in vivo [8,9]. To date, hydrazones based on menthone and camphor were found to prevent seizures spread in the maximal electroshock (MES) test showing simultaneously low neurotoxicity [10,11].

In this study, bicyclic terpenoid (−)-verbenone was used as a base for hydrazone synthesis via its condensation with hydrazides of para-substituted phenoxyacetic acid. As known earlier, phenoxyacetic acid derivatives also possess the peripheral nociceptive action and anticonvulsant effect [12,13]. Taking into account the foregoing, a series of novel (−)-verbenone hydrazones were designed and synthesized, and their spectral characteristics have been described followed by their investigation as potential analgesic and anticonvulsant agents using different experimental models in vivo.

2 Materials and methods

2.1 General

The following chemicals were obtained from commercial sources and used without further purification: (−)-verbenone, 4-chlorophenol, 4-phenoxyphenol, 4-bromophenol, 4-tert-butylphenol and phenol (TCI, USA). Compounds 2a–2e were synthesized in three steps starting from para-substituted phenols as previously reported [14]. The products were characterized by 1H-NMR spectroscopy on AVANCE DRX 500 (500 MHz) instrument and by 13C-NMR spectroscopy on Varian-Mercury 400 spectrometer with the use of DMSO-d6 as a solvent and tetramethylsilane as an internal standard. FAB mass spectra were recorded on a VG 70-70EQ mass spectrometer equipped with Xe ion gun (8 kV); the samples were mixed with m-nitrobenzyl-alcohol matrix. High-resolution mass spectrometry (HRMS) was carried out on a 6530 Accurate Mass quadrupole time-of-flight (Q-TOF) spectrometer by means of electrospray ionization method (ESI) coupled to an Agilent 1260 Infinity HPLC system. Chromatographic separation was performed on Agilent ZORBAX Eclipse Plus C18 column (100 mm × 4.6 mm, 3.5 µm) at 35°C. Elution was executed at a flow rate of 1.0 mL/min, and the injection volume was 1 µL. IR spectra were recorded on PerkinElmer Frontier FT-IR spectrometer with samples in KBr disks. Raman spectra were obtained on Thermo Fisher Scientific DXR Raman Microscope. Differential scanning calorimetry (DSC) was carried out on Q2000 Differential Scanning Calorimeter with the use of aluminum crucibles containing 2 mg of compounds 3a–3e under dynamic nitrogen atmosphere and the heating rate of 1°C min−1 at temperature ranging from 20 to 200°C.

2.2 General procedure to the synthesis of (−)-verbenone hydrazones (3a–3e)

To solution of (−)-verbenone (2.0 g, 13.3 mmol) in propanol (50 mL), the equimolar amount (13.3 mmol) of compounds 2a–2e and 2–3 drops of CH3COOH (glacial) were added. The reaction mixture was refluxed for 12 h, then cooled to room temperature and poured into the ice. The obtained precipitate was filtered and dried under vacuum followed by the recrystallization from methanol.

2.2.1 2-Phenoxy-N′-[4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ylidene]acetohydrazide (3a)

Yield 78%; white solid. 1H-NMR (500 MHz, DMSO-d6) δ: 0.83 (s, 3H, H-8), 1.42 (s, 3H, H-9), 1.60 (d, J = 8.8 Hz, 1H, H-7endo), 1.91 (t, 3H, H-10), 2.27 (dd, J = 6.0 Hz, J = 1.8 Hz, 1H, H-5), 2.63–2.67 (m, 1H, H-1), 4.61 (s, 1H, CH2), 4.96–4.98 (m, 1H, CH2), 5.82 (d, J = 9.6 Hz, 1H, H-3), 6.85 (d, J = 7.8 Hz, 1H, Ar–H), 6.93 (t, 1H, Ar–H), 6.99 (d, J = 8.5 Hz, 1H, Ar–H), 7.28 (t, 2H, Ar–H). 13C-NMR (100 MHz, DMSO-d6) δ: 169.7; 167.3 (C═O), 158.7 (Ar–C), 157.5 (C-2), 155.4 (C-4), 130.0 (Ar–C), 129.8 (Ar–C), 121.7 (Ar–C), 115.0 (Ar–C), 114.9 (Ar–C), 110.5 (C-3), 66.5; 65.2 (CH2), 48.8 (C-1), 47.8 (C-6), 43.6 (C-5), 42.9 (C-7), 26.3 (C-9), 23.2 (C-8), 22.5 (C-10). FT-IR (νmax, cm−1): 3,468 (N–H), 3197 (C–H, Ar), 2,970‒2,934 (C–H), 1,697 (C═O), 1,661 (C═N), 1,599 (C–C, Ar), 838–688 (C–H, Ar). Raman (νmax, cm−1): 3,073 (N–H), 3,030 (C–H, Ar), 2,993–2,837 (C–H), 1,686 (C═O), 1,640 (C═N). MS (FAB) m/z: 299 [M + H]+. HRMS (ESI-TOF) calculated for C18H22N2O2 [M]+ 298.379, found 298.385. HPLC: tr = 4.9 min; 5.3 min. M.p. (DSC) onset: 145.52°C, peak max: 149.22°C (first peak); onset: 154.91°C, peak max: 155.89°C (second peak).

2.2.2 2-(4-Bromophenoxy)-N′-[4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ylidene]acetohydrazide (3b)

Yield 82%; white solid. 1H-NMR (500 MHz, DMSO-d6) δ: 0.83 (s, 3H, H-8), 1.41 (s, 3H, H-9), 1.58 (d, J = 8.2 Hz, 1H, H-7endo), 1.90 (t, 3H, H-10), 2.27 (dd, J = 6.0 Hz, J = 1.8 Hz, 1H, H-5), 2.64 (dd, J = 5.9 Hz, J = 1.7 Hz, 1H, H-1), 4.63 (d, J = 7.7 Hz, 1H, CH2), 4.98 (d, J = 7.7 Hz, 1H, CH2), 5.81 (d, J = 16.6 Hz, 1H, H-3), 6.84 (d, J = 8.2 Hz, 1H, Ar–H), 6.91–6.93 (m, 1H, Ar–H), 7.41 (d, J = 8.2 Hz, 1H, Ar–H), 7.44 (d, J = 7.7 Hz, 1H, Ar–H). 13C-NMR (100 MHz, DMSO-d6) δ: 169.1; 166.8 (C═O), 160.4 (Ar–C), 158.1 (C-2), 155.1 (C-4), 132.6 (Ar–C), 132.4 (Ar–C), 119.0 (Ar–C), 117.5 (Ar–C), 117.2 (Ar–C), 110.5 (C-3), 66.9; 65.5 (CH2), 51.3 (C-1), 49.1 (C-6), 43.6 (C-5), 42.9 (C-7), 26.3 (C-9), 23.1 (C-8), 22.1 (C-10). FT-IR (νmax, cm−1): 3,418 (N–H), 3,204 (C–H, Ar), 2,977‒2,937 (C–H), 1,698 (C═O), 1,669 (C═N), 1,489 (C–C, Ar), 817–606 (C–H, Ar). Raman (νmax, cm−1): 3,090 (N–H), 3,072 (C–H, Ar), 2,993–2,805 (C–H), 1,680 (C═O), 1,640 (C═N). MS (FAB) m/z: 377 [M]+. HRMS (ESI-TOF) calculated for C18H21BrN2O2 [M]+ 377.276, found 378.374. HPLC: tr = 9.1 min; 9.9 min. M.p. (DSC) onset: 167.86°C, peak max: 170.91°C (first peak); onset: 174.64°C, peak max: 176.29°C (second peak).

2.2.3 2-(4-Chlorophenoxy)-N′-[4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ylidene]acetohydrazide (3c)

Yield 84%; white solid. 1H-NMR (500 MHz, DMSO-d6) δ: 0.82 (s, 3H, H-8), 1.42 (s, 3H, H-9), 1.59 (d, J = 8.2 Hz, 1H, H-7endo), 1.90 (t, 3H, H-10), 2.27 (dd, J = 6.0 Hz, J = 1.8 Hz, 1H, H-5), 2.65 (dd, J = 5.9 Hz, J = 1.7 Hz, 1H, H-1), 4.62 (d, J = 7.7 Hz, 1H, CH2), 4.97 (d, J = 7.7 Hz, 1H, CH2), 5.82 (d, J = 16.6 Hz, 1H, H-3), 6.85 (d, J = 8.2 Hz, 1H, Ar–H), 6.94–6.96 (m, 2H, Ar–H), 7.26 (d, J = 8.2 Hz, 1H, Ar–H). 13C-NMR (100 MHz, DMSO-d6) δ: 169.1; 167.8 (C═O), 160.8 (Ar–C), 158.6 (C-2), 155.3 (C-4), 132.9 (Ar–C), 132.4 (Ar–C), 119.0 (Ar–C), 117.7 (Ar–C), 117.2 (Ar–C), 110.5 (C-3), 66.9; 65.6 (CH2), 51.3 (C-1), 49.1 (C-6), 43.6 (C-5), 42.9 (C-7), 26.3 (C-9), 23.1 (C-8), 22.1 (C-10). FT-IR (νmax, cm−1): 3,466–3,414 (N–H), 3,205 (C–H, Ar), 2,979‒2,938 (C–H), 1,697 (C═O), 1,671 (C═N), 1,549 (C–C, Ar), 818–709 (C–H, Ar). Raman (νmax, cm−1): 3,070 (C–H, Ar), 2,977–2,828 (C–H), 1,679 (C═O), 1,642 (C═N). MS (FAB) m/z: 333 [M]+. HRMS (ESI-TOF) calculated for C18H21ClN2O2 [M]+ 332.824, found 332.038. HPLC: tr = 8.0 min; 8.7 min. M.p. (DSC) onset: 117.35°C, peak max: 140.76°C (first peak); onset: 163.02°C, peak max: 171.38°C (second peak).

2.2.4 2-(4-tert-Butylphenoxy)-N′-[4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ylidene]acetohydrazide (3d)

Yield 70%; white solid. 1H-NMR (500 MHz, DMSO-d6) δ: 0.82 (s, 3H, H-8), 1.24 (s, 9H, C(CH3)3), 1.41 (s, 3H, H-9), 1.59 (d, J = 8.3 Hz, 1H, H-7endo), 1.91 (t, 3H, H-10), 2.27 (dd, J = 6.0 Hz, J = 1.8 Hz, 1H, H-5), 2.64 (dd, J = 5.9 Hz, J = 1.7 Hz, 1H, H-1), 4.58 (d, J = 7.2 Hz, 1H, CH2), 4.92 (d, J = 6.5 Hz, 1H, CH2), 5.81 (d, J = 10.9 Hz, 1H, H-3), 6.76–6.86 (m, 2H, Ar–H), 7.25–7.28 (m, 2H, Ar–H). 13C-NMR (100 MHz, DMSO-d6) δ: 169.5; 164.4 (C═O), 160.3 (Ar–C), 156.5 (C-2), 154.9 (C-4), 143.2 (Ar–C), 126.5 (Ar–C), 126.4 (Ar–C), 114.4 (Ar–C), 114.3 (Ar–C), 110.5 (C-3), 66.4; 65.2 (CH2), 51.3 (C-1), 49.1 (C-6), 43.5 (C-5), 42.8 (C-7), 34.2 (C(CH3)3), 31.8 (CH3), 26.3 (C-9), 23.1 (C-8), 22.1 (C-10). FT-IR (νmax, cm−1): 3,552–3,414 (N–H), 3,232 (C–H, Ar), 2,961‒2,863 (C–H), 1,702 (C═O), 1,638 (C═N), 1,616‒1,596 (C–C, Ar), 828–611 (C–H, Ar). Raman (νmax, cm−1): 3,075 (N–H), 3,038 (C–H, Ar), 2,990–2,832 (C–H), 1,677 (C═O), 1,642 (C═N). MS (FAB) m/z: 355 [M + H]+. HRMS (ESI-TOF) calculated for C22H30N2O2 [M]+ 354.486, found 354.456. HPLC: tr = 21.3 min; 23.3 min. M.p. (DSC) onset: 166.36°C, peak max: 170.14°C (first peak); onset: 172.50°C, peak max: 173.62°C (second peak).

2.2.5 2-(4-Phenoxyphenoxy)-N′-[4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ylidene]acetohydrazide (3e)

Yield 74%; white solid. 1H-NMR (500 MHz, DMSO-d6) δ: 0.83 (s, 3H, H-8), 1.41 (s, 3H, H-9), 1.60 (s, 1H, H-7endo), 1.90 (t, 3H, H-10), 2.26 (m, 1H, H-5), 2.65 (m, 1H, H-1), 4.62 (s, 1H, CH2), 4.96 (s, 1H, CH2), 5.82 (d, J = 12.0 Hz, 1H, H-3), 6.91 (d, J = 6.8 Hz, 2H, Ar–H), 6.99 (s, 4H, Ar–H), 7.06 (t, 1H, Ar–H), 7.34 (t, 2H, Ar–H). 13C-NMR (100 MHz, DMSO-d6) δ: 166.5; 164.2 (C═O), 158.4 (Ar–C), 155.0 (Ar–C), 149.9 (C-2), 144.9 (Ar–C), 135.4 (C-4), 130.4 (Ar–C), 123.1 (Ar–C), 121.1 (Ar–C), 117.8 (Ar–C), 116.3 (Ar–C), 110.5 (C-3), 66.9; 65.8 (CH2), 51.3 (C-1), 49.1 (C-6), 43.4 (C-5), 42.9 (C-7), 26.3 (C-9), 24.1 (C-8), 22.5 (C-10). FT-IR (νmax, cm−1): 3,552–3,415 (N–H), 3,231–3,194 (C–H, Ar), 2,953‒2,867 (C–H), 1,681 (C═O), 1,638 (C═N), 1,616 (C–C, Ar), 836 (C–H, Ar). Raman (νmax, cm−1): 3,060 (C–H, Ar), 2,990–2,828 (C–H), 1,685 (C═O), 1,644 (C═N). MS (FAB) m/z: 391 [M + H]+. HRMS (ESI-TOF) calculated for C24H26N2O3 [M]+ 390.474, found 389.950. HPLC: tr = 15.8 min; 17.3 min. M.p. (DSC) onset: 87.15°C, peak max: 92.29°C (first peak); onset: 122.70°C, peak max: 132.31°C (second peak).

2.3 Anticonvulsant activity

2.3.1 Pentylenetetrazole (PTZ)-induced seizures

The anticonvulsant effect of hydrazones 3a–3e was evaluated by intravenous injection of 1% aqueous solution of PTZ into a tail vein as described in Ref. [15]. Pure (−)-verbenone at a dose of 50 mg/kg in Tween 80/water emulsion has been administered to mice orally. Hydrazones 3a–3e were used in equimolar to verbenone doses, and Tween 80/water emulsion served as a vehicle control and valproic acid (VPA, 400 mg/kg) ‒ as a reference drug [16]. PTZ doses that induced clonic–tonic convulsions (DCTC) and tonic extension (DTE) in experimental animals were calculated with respect to control. The anticonvulsant effect of compounds was assessed at different time points (6 and 24 h) from the increase of PTZ minimum effective dose (MED) in comparison to the control group. MED (in %) was determined according to the following formula:

MED=V/m×104,

taking into account the volume of PTZ solution (in mL) and the weight of each animal (in g); 104 – conversion factor for animal weight (g to kg, 103) and dose of PTZ (mL of PTZ solution to mg of PTZ, 10).

2.3.2 MES-induced seizures

In this method, corneal electrodes (50 mA, 50 Hz) have been applied to induce seizures in experimental animals (mice) pretreated with compounds 3a–3e as described in Section 2.3.1. The percent of mortality was considered as an index of seizure protection.

2.4 Analgesic action

The analgesic activity of verbenone hydrazones 3a–3e was estimated by their topical application as 2% w/w ointments. Pain in experimental animals was induced by chemical stimuli, that is, by subcutaneous injection of TRPV1 and TRPA1 selective agonists –capsaicin and allyl isothiocyanate (AITC) with subsequent identification of pain index as described in our previous study [17]. The study was approved by the Animal Ethics Committee (agreement no. 04/2020) of Odessa National Polytechnic University (Ukraine).

2.5 Statistical analysis

All results are expressed as mean ± standard error mean (SEM). One-way analysis of variance was used to determine the statistical significance of the results followed by Tukey’s post hoc comparison. p < 0.05 was considered as statistically significant.

3 Results and discussion

3.1 Chemistry

The synthesis of (−)-verbenone hydrazones 3a–3e was performed via condensation of 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one 1 with hydrazides of 4-R-phenoxyacetic acid (2a–2e) using a catalytic amount of CH3COOH (glacial), according to Scheme 1.

Scheme 1 Synthesis of (−)-verbenone hydrazones. Reagents and conditions: (i) AcOH (glacial), n-PrOH, reflux, 12 h.
Scheme 1

Synthesis of (−)-verbenone hydrazones. Reagents and conditions: (i) AcOH (glacial), n-PrOH, reflux, 12 h.

Here, we have to notice that condensation of bicyclic terpenoid verbenone with hydrazides requires more harsh reaction conditions (reflux for 12 h in n-PrOH), whereas monocyclic terpenoids (such as menthone or carvone [18,19]) react under mild conditions (reflux for 4 h in MeOH).

Hydrazones 3a–3e were isolated in 70–84% yield after recrystallization from methanol as white solids soluble in organic solvents such as acetonitrile and chloroform (Figure 1).

Figure 1 Structures of (−)-verbenone hydrazones 3a–3e.
Figure 1

Structures of (−)-verbenone hydrazones 3a–3e.

The formation of verbenone derivatives was elucidated by mass spectrometry – molecular ion peaks of target compounds 3a–3e correspond to their molecular formulas (FAB and ESI). The FT-IR spectra of verbenone hydrazones exhibit absorption bands of C═O and C═N groups, N–H bonds and alkyl and aromatic C–H. In addition, the formation of C═N bond of hydrazones was confirmed by Raman spectroscopy as intense peak at 1,640–1,644 cm−1. Chemical shift, multiplicity and coupling constants observed in 1H-NMR and 13C NMR spectra prove the proposed structure of compounds 3a–3e. Phase transitions (melting points) of derivatives 3a–3e have been studied by DSC. The purity of (−)-verbenone derivatives was estimated by HPLC analysis using a mixture of acetonitrile and formic acid aqueous solution (0.01%) in 50:50 ratio as the eluent system. According to the HPLC analysis, two chromatographic peaks were revealed identifying the presence of Z/E geometrical isomers of verbenone hydrazones about C═N bond that was additionally supported by the MS data. Retention time recorded for these peaks ranges from 4.9 to 21.3 min (first peak) and from 5.3 to 23.3 min (second peak).

Along with Z/E geometrical isomers, hydrazones were proven to exist in solution as a mixture of cis/trans conformers caused by hindered rotation on the C‒N amide bond [20]. The existence of verbenone hydrazones as cis/trans conformers was reliably corroborated by 1H NMR analysis – the protons of methylene group (CH2) appear as two sets of signals. As described, in DMSO-d6 solutions of hydrazones, both cis and trans amide conformers are formed; nevertheless, cis form is dominated due to the formation of dimers that are stabilized by hydrogen bonds between CO and NH groups [20,21]. The upfield peak of the methylene group corresponds to trans conformer, while downfield peak corresponds to cis form [20]. We have to emphasize that 1H NMR spectral data of compounds 3a–3e displayed the similar pattern ‒ two singlets for protons of methylene group (4.58–4.63 and 4.92–4.98 ppm). 13C NMR spectra of hydrazones 3a–3e contain also two resonance signals of methylene carbons (66.4–66.9 and 65.2–65.8 ppm) along with two signals of carbonyl carbons (166.5–169.7 and 164.2–167.8 ppm) (Table 1).

Table 1

1H and 13C NMR data of cis/trans conformers of compounds 3a–3e in DMSO-d6

CompoundConformer1H NMR ‒CH2‒ (δ, ppm)13C NMR ‒CH2‒ (δ, ppm)13C NMR ‒C═O (δ, ppm)
3acis4.9765.2169.7
trans4.6166.5167.3
3bcis4.9865.5169.1
trans4.6366.9166.8
3ccis4.9765.6169.1
trans4.6266.9167.8
3dcis4.9265.2169.5
trans4.5866.4164.4
3ecis4.9665.8166.5
trans4.6266.9164.2

In this case, upfield signals of carbonyl carbons and downfield lines of methylene carbons refer to amide trans conformer, while downfield lines of carbonyl carbons and upfield signals of methylene carbons are assigned to cis conformer [22]. Thus, we may conclude that according to 1H NMR and 13C NMR analysis target verbenone derivatives 3a–3e present in DMSO-d6 solution both in cis and trans form.

3.2 Anticonvulsant activity

Considering the antiseizure effect of pure terpenoids and taking into account the high reactivity of pharmacophore group ‒CO‒NH‒N═CH‒, significant interest is focused on hydrazones based on terpenoids as scaffold [8,23].

Antiseizure action of verbenone hydrazones 3a–3e was elucidated both on models of chemically and electrically induced seizures at 6 and 24 h after their single oral administration. As illustrated in Figure 2, starting terpenoid along with derivatives 3a–3e demonstrated protective effect against PTZ-induced seizures at 6 h after administration as corroborated by increasing of DCTC and DTE values compared with control (100%).

Figure 2 Anticonvulsant activity of compounds 3a–3e at 6 h after oral administration. Values are given as mean ± SEM, n = 5 mice; for all groups p < 0.01 compared with control; **p < 0.01 compared with VPA.
Figure 2

Anticonvulsant activity of compounds 3a–3e at 6 h after oral administration. Values are given as mean ± SEM, n = 5 mice; for all groups p < 0.01 compared with control; **p < 0.01 compared with VPA.

At this time point, compound 3b (with bromine atom at the para position of benzene ring) was shown to possess maximal anticonvulsant activity with the average values: 278% for DCTC and 303% for DTE. Interestingly, reference anticonvulsant drug VPA (400 mg/kg, p.o.) is inferior in action to hydrazones 3a–3d (p < 0.01).

Bearing in mind the enzymatic cleavage of C═N double bond in hydrazone molecules [24] and, consequently, their possible prolonged action, anticonvulsant estimation was additionally performed at 24 h after administration (Figure 3).

Figure 3 Anticonvulsant activity of compounds 3a–3e at 24 h after oral administration. Values are given as mean ± SEM, n = 5 mice; for all groups p < 0.01 compared with control; **p < 0.01 compared with VPA.
Figure 3

Anticonvulsant activity of compounds 3a–3e at 24 h after oral administration. Values are given as mean ± SEM, n = 5 mice; for all groups p < 0.01 compared with control; **p < 0.01 compared with VPA.

In the PTZ-induced convulsion model, antiseizure action was manifested in experimental animal groups treated with verbenone hydrazones 3a–3e at 24 h after oral administration demonstrating DCTC and DTE values on average 212% and 214%, accordingly, in comparison with the control data (100%) that point out to a significant prolonged action. Furthermore, compounds 3a–3e exhibited higher anticonvulsant potency at long time period versus VPA (p < 0.01) that might be interpreted by enzymatic cleavage of labile bonds (N‒N or C‒N amide bond) in hydrazone molecules followed by gradual release of active ingredients. Moreover, the prolonged presence of verbenone derivatives in the body may also be realized due to their lipophilicity (log P for 3a–3e ranges from 3.66 to 5.35, log P for VPA is 2.72; ACD/Labs software). Low activity of pure verbenone (log P 1.97) at 24 h after administration (130% for DCTC and 138 for DTE) is explained, in turn, by its excretion at this time point.

Anticonvulsant potency of verbenone hydrazones was additionally assessed in the MES test that is considered as generalized tonic–clonic seizure model and reflects the ability of compounds to prevent seizure spread throughout the brain [25]. According to the data of the MES test, electrical stimuli induced the rigid extension of the hind limbs in 100% of control animals (Table 2).

Table 2

Anticonvulsant effect of compounds 3a–3e against maximal electroshock (MES)-induced seizures in mice

Compound3a3b3c3d3eVerbenoneVPAControl
6 h after single oral administration
% Mortality protection8080801006060800
24 h after single oral administration
% Mortality protection8010060608020600

As mentioned earlier, hydrazones 3a–3d substantially prevented the mortality of animals at 6 h after administration and showed 80–100% protection, which is comparable to the effect of VPA (80%), while moderate antiseizure action was observed for compound 3e and starting verbenone (60%). Interestingly, the activity of the aforementioned hydrazones is maintained for a long time period (24 h) with 60–100% of mortality protection. In turn, pure verbenone administered 24 h prior to the test produced weak action in mice with only 20% of protection. We have to emphasize that seizures in the MES test were characterized by Straub tail when the mice were orally pretreated with compounds 3a–3e. This phenomenon consisted of the mouse tail becoming rigid and erected across the back of the animal in an S-shaped curve [26]. Straub reaction in mice is described as one of the techniques for indicating analgesic and addicting properties of novel compounds [27]. Although Straub tail response is thought to be mediated by activation of the opioid receptor mechanism, this reaction can also be caused by dopaminergic, α-2 noradrenergic and nicotinic acetylcholine receptor agonists [28,29].

3.3 Analgesic action

Bearing in mind the aforementioned Straub reaction and molecular targets of terpenoids (transient receptor potential [TRP] channels), verbenone hydrazones 3a–3e were examined as potential analgesic agents by their topical application using agonists of TRP channels to induce the pain. Analgesic activity of compounds 3a–3e was comparable with the standard drug benzocaine (BZC) used as a topical pain reliever that activates both TRPV1 and TRPA1 channels [30]. As presented in Table 3, after the treatment with the ointment comprising either verbenone or its derivatives 3a–3e, the reaction time recorded in the capsaicin test statistically differed from the control data (p < 0.01 vs control animals). Positive control (BZC) was also manifested to decrease the licking time to 9 ± 1 s, affirming its significant effect on TRPV1 channel. Despite the fact that synthesized compounds 3a–3e along with pure verbenone reduced pain sensitivity threshold, they were inferior to BZC when topically applied.

Table 3

Analgesic activity of hydrazones 3a–3e on capsaicin- and AITC-induced acute pain in mice (2% w/w ointment)

CompoundLicking time (in s)
Capsaicin testAITC test
Control54 ± 363 ± 2
Benzocaine9 ± 138 ± 4
Verbenone32 ± 245 ± 6
3a26 ± 531 ± 5
3b21 ± 134 ± 3
3c27 ± 632 ± 7
3d23 ± 246 ± 7
3e43 ± 146 ± 3

All values are expressed as mean ± SEM; n = 5; for all groups, p < 0.01 compared with control group.

The intraplantar injection of TRPA1 channel antagonist (AITC) after the application of ointment base led to the occurrence of pain sensations with licking time duration of 63 ± 2 s, whereas for reference drug (BZC), this value was 38 ± 4 s. When treated with verbenone or its hydrazones 3a–3e, the reaction time ranged from 31 to 46 s, reflecting that these derivatives significantly attenuate AITC-induced acute pain and possess an analgesic action comparable with that in BZC treatment. Given the results of analgesic trials, TRPA1 and TRPV1 ion channels might be proposed as one of the molecular targets for compounds 3a–3e.

4 Conclusion

Hydrazones based on bicyclic terpenoid (−)-verbenone were synthesized as promising compounds simultaneously affecting both the central and peripheral nervous system. Verbenone derivatives 3a–3e have been demonstrated to protect against electroshock- and PTZ-induced seizures at different time points – 6 and 24 h after oral administration. Binding of verbenone hydrazones to TRPA1/TRPV1 ion channels has been suggested as a feasible mechanism for explanation of significant analgesic activity of obtained compounds.

Abbreviations

AITC

allyl isothiocyanate

BZC

benzocaine

DCTC

dose inducing clonic–tonic convulsions

DSC

differential scanning calorimetry

DTE

dose inducing tonic extension

ESI

electrospray ionization method

GABA

gamma-aminobutyric acid

HRMS

high-resolution mass spectrometry

MED

minimum effective dose

MES

maximal electroshock

PTZ

pentylenetetrazol

SEM

standard error mean

TOF

time-of-flight

TRP

transient receptor potential

VPA

valproic acid


tel: +38-093-713-3853

  1. Conflict of interest: No potential conflict of interest was reported by the authors.

References

[1] Nakatsu T, Lupo AT, Chinn JW, Kang RKL. Biological activity of essential oils and their constituents. Stud Nat Prod Chem. 2000;21:571–631.10.1016/S1572-5995(00)80014-9Search in Google Scholar

[2] Guetat A, Al-Ghamdi FA, Osman AK. 1,8-Cineole, α-pinene and verbenone chemotype of essential oil of species Rosmarinus officinalis L. from Saudi Arabia. Int J Herb Med. 2014;2(2):137–41.Search in Google Scholar

[3] Shamsardakani MR, Mosaddegh M, Shafaati A. Volatile constituents from the aerial parts of Verbena Officinalis L. (Vervain). Iran J Pharm Res. 2003;2(1):39–42.Search in Google Scholar

[4] Andrade JM, Faustino C, Garcia C, Ladeiras D, Reis CP, Rijo P. Rosmarinus officinalis L.: an update review of its phytochemistry and biological activity. Future Sci OA. 2018;4(4):FSO283.10.4155/fsoa-2017-0124Search in Google Scholar PubMed PubMed Central

[5] de Melo CGF, Salgado PRR, da Fonsêca DV, Braga RM, Filho M, de Farias I, et al. Anticonvulsive activity of (1S)-(−)-verbenone involving RNA expression of BDNF, COX-2, and c-fos. Naunyn-Schmiedeberg’s Arch Pharmacol. 2017;390:863–9.10.1007/s00210-017-1388-xSearch in Google Scholar PubMed

[6] Chen J, Jiang QD, Chai YP, Zhang H, Peng P, Yang XX. Natural terpenes as penetration enhancers for transdermal drug delivery. Molecules. 2016;21(12):1–22.10.3390/molecules21121709Search in Google Scholar PubMed PubMed Central

[7] Nesterkina MV, Kravchenko IA. Synthesis and anticonvulsant activity of menthyl γ-aminobutyrate. Chem Nat Compd. 2016;52(2):237–9.10.1007/s10600-016-1604-9Search in Google Scholar

[8] Angelova V, Karabeliov V, Andreeva-Gateva PA, Tchekalarova J. Recent developments of hydrazide/hydrazone derivatives and their analogs as anticonvulsant agents in animal models. Drug Dev Res. 2016;77(7):379–92.10.1002/ddr.21329Search in Google Scholar PubMed

[9] Rollas S, Küçükgüzel SG. Biological activities of hydrazone derivatives. Molecules. 2007;12(8):1910–39.10.3390/12081910Search in Google Scholar PubMed PubMed Central

[10] Jain J, Kumar Y, Sinha R, Kumar R, Stables J. Menthone aryl acid hydrazones: a new class of anticonvulsants. Med Chem. 2011;7(1):56–61.10.2174/157340611794072689Search in Google Scholar PubMed

[11] Agrawal S, Jain J, Kumar A, Gupta P, Garg V. Synthesis molecular modeling and anticonvulsant activity of some hydrazone, semicarbazone, and thiosemicarbazone derivatives of benzylidene camphor. Res Rep Med Chem. 2014;4:47–58.10.2147/RRMC.S66115Search in Google Scholar

[12] Turan-Zitouni G, Yurttaş L, Kaplancıklı ZA, Can ÖD, Özkay ÜD. Synthesis and anti-nociceptive, anti-inflammatory activities of new aroyl propionic acid derivatives including N-acylhydrazone motif. Med Chem Res. 2015;24:2406–16.10.1007/s00044-014-1309-1Search in Google Scholar

[13] Pages N, Maurois P, Bac P, Eynde JJV, Tamariz J, Labarrios F, et al. The ⍺-asarone/clofibrate hybrid compound, 2-methoxy-4-(2-propenyl)phenoxyacetic acid (MPPA), is endowed with neuroprotective and anticonvulsant potentialities. Biomed Aging Pathol. 2011;1:210–5.10.1016/j.biomag.2011.09.005Search in Google Scholar

[14] Kaur P, Kaur R, Goswami M. A review on methods of synthesis of 1,2,4-triazole derivatives. IRJP. 2018;9:1–35.10.7897/2230-8407.097121Search in Google Scholar

[15] Nesterkina MV, Alekseeva EA, Kravchenko IA. Synthesis, physicochemical properties, and anticonvulsant activity of the GABA complex with a calix[4]arene derivative. Pharm Chem J. 2014;48(2):82–4.10.1007/s11094-014-1052-4Search in Google Scholar

[16] Li B, Wang L, Sun Z, Zhou Y, Shao D, Zhao J, et al. The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in mice. PLoS One. 2014;9(14):1–6.10.1371/journal.pone.0093158Search in Google Scholar

[17] Kravchenko I, Eberle L, Nesterkina M, Kobernik A. Anti-inflammatory and analgesic activity of ointment based on dense ginger extract (Zingiber officinale). J Herbmed Pharmacol. 2019;8(2):126–32.10.15171/jhp.2019.20Search in Google Scholar

[18] Nesterkina M, Barbalat D, Zheltvay I, Rakipov I, Atakay M, Salih B, et al. (2S,5R)-2-Isopropyl-5-methylcyclohexanone hydrazones. Molbank. 2019;2019(2):M1062.10.3390/M1062Search in Google Scholar

[19] Nesterkina M, Barbalat D, Konovalova I, Shishkina S, Atakay M, Salih B, et al. Novel (−)-carvone derivatives as potential anticonvulsant and analgesic agents. Nat Prod Res. 2020. doi: 10.1080/14786419.2020.1756804.Search in Google Scholar

[20] Palla G, Predieri G, Domiano P, Vignali C, Turner W. Conformational behaviour and E/Z isomerization of N-acyl and N-aroylhydrazones. Tetrahedron. 1986;42(13):3649–54.10.1016/S0040-4020(01)87332-4Search in Google Scholar

[21] Johansson A, Kollman P, Rothenberg S, McKelvey J. Hydrogen bonding ability of the amide group. J Am Chem Soc. 1974;96(12):3794–800.10.1021/ja00819a013Search in Google Scholar

[22] Patorski P, Wyrzykiewicz E, Bartkowiak G. Synthesis and conformational assignment of N-(E)-stilbenyloxymethylenecarbonyl-substituted hydrazones of acetone and o-(m- and p-) chloro- (nitro-) benzaldehydes by means of 1H and 13C NMR spectroscopy. J Spectrosc. 2013;2013:1–12.10.1155/2013/197475Search in Google Scholar

[23] Manayi A, Nabavi SM, Daglia M, Jafari S. Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases. Pharmacol Rep 2016;68(4):671–9.10.1016/j.pharep.2016.03.014Search in Google Scholar

[24] Itoh H, Suzuta T, Hoshino T, Takaya N. Novel dehydrogenase catalyzes oxidative hydrolysis of carbon–nitrogen double bonds for hydrazone degradation. J Biol Chem. 2008;283(9):5790–800.10.1074/jbc.M709027200Search in Google Scholar

[25] Mandhane SN, Aavula K, Rajamannar T. Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure. 2007;16(7):636–44.10.1016/j.seizure.2007.05.005Search in Google Scholar

[26] Bilbey DL, Salem H, Grossman MH. The anatomical basis of the straub phenomenon. Br J Pharmacol Chemother. 1960;15(4):540–3.10.1111/j.1476-5381.1960.tb00277.xSearch in Google Scholar

[27] Laurence DR, Bacharach AL. Evaluation of drug activities. 1st ed. London: Academic Press; 1964.Search in Google Scholar

[28] Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Tanaka K, Nishiyama N, et al. Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine. Brain Res 2012;1482:40–6.10.1016/j.brainres.2012.09.001Search in Google Scholar

[29] Nath C, Gupta MB, Patnaik GK, Dhawan KN. Morphine-induced straub tail response: mediated by central μ2-opioid receptor. Eur J Pharmacol. 1994;263(1–2):203–5.10.1016/0014-2999(94)90543-6Search in Google Scholar

[30] Leffler AL, Fischer MJ, Rehner D, Kienel S, Kistner K, Sauer SK, et al. The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest. 2008;118(2):763–76.10.1172/JCI32751Search in Google Scholar PubMed PubMed Central

Received: 2020-05-01
Revised: 2020-06-16
Accepted: 2020-06-17
Published Online: 2020-08-07

© 2020 Mariia Nesterkina et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Regular Articles
  2. Electrochemical antioxidant screening and evaluation based on guanine and chitosan immobilized MoS2 nanosheet modified glassy carbon electrode (guanine/CS/MoS2/GCE)
  3. Kinetic models of the extraction of vanillic acid from pumpkin seeds
  4. On the maximum ABC index of bipartite graphs without pendent vertices
  5. Estimation of the total antioxidant potential in the meat samples using thin-layer chromatography
  6. Molecular dynamics simulation of sI methane hydrate under compression and tension
  7. Spatial distribution and potential ecological risk assessment of some trace elements in sediments and grey mangrove (Avicennia marina) along the Arabian Gulf coast, Saudi Arabia
  8. Amino-functionalized graphene oxide for Cr(VI), Cu(II), Pb(II) and Cd(II) removal from industrial wastewater
  9. Chemical composition and in vitro activity of Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. essential oils towards oral isolates of Candida albicans and Candida glabrata
  10. Effect of excess Fluoride consumption on Urine-Serum Fluorides, Dental state and Thyroid Hormones among children in “Talab Sarai” Punjab Pakistan
  11. Design, Synthesis and Characterization of Novel Isoxazole Tagged Indole Hybrid Compounds
  12. Comparison of kinetic and enzymatic properties of intracellular phosphoserine aminotransferases from alkaliphilic and neutralophilic bacteria
  13. Green Organic Solvent-Free Oxidation of Alkylarenes with tert-Butyl Hydroperoxide Catalyzed by Water-Soluble Copper Complex
  14. Ducrosia ismaelis Asch. essential oil: chemical composition profile and anticancer, antimicrobial and antioxidant potential assessment
  15. DFT calculations as an efficient tool for prediction of Raman and infra-red spectra and activities of newly synthesized cathinones
  16. Influence of Chemical Osmosis on Solute Transport and Fluid Velocity in Clay Soils
  17. A New fatty acid and some triterpenoids from propolis of Nkambe (North-West Region, Cameroon) and evaluation of the antiradical scavenging activity of their extracts
  18. Antiplasmodial Activity of Stigmastane Steroids from Dryobalanops oblongifolia Stem Bark
  19. Rapid identification of direct-acting pancreatic protectants from Cyclocarya paliurus leaves tea by the method of serum pharmacochemistry combined with target cell extraction
  20. Immobilization of Pseudomonas aeruginosa static biomass on eggshell powder for on-line preconcentration and determination of Cr (VI)
  21. Assessment of methyl 2-({[(4,6-dimethoxypyrimidin-2-yl)carbamoyl] sulfamoyl}methyl)benzoate through biotic and abiotic degradation modes
  22. Stability of natural polyphenol fisetin in eye drops Stability of fisetin in eye drops
  23. Production of a bioflocculant by using activated sludge and its application in Pb(II) removal from aqueous solution
  24. Molecular Properties of Carbon Crystal Cubic Structures
  25. Synthesis and characterization of calcium carbonate whisker from yellow phosphorus slag
  26. Study on the interaction between catechin and cholesterol by the density functional theory
  27. Analysis of some pharmaceuticals in the presence of their synthetic impurities by applying hybrid micelle liquid chromatography
  28. Two mixed-ligand coordination polymers based on 2,5-thiophenedicarboxylic acid and flexible N-donor ligands: the protective effect on periodontitis via reducing the release of IL-1β and TNF-α
  29. Incorporation of silver stearate nanoparticles in methacrylate polymeric monoliths for hemeprotein isolation
  30. Development of ultrasound-assisted dispersive solid-phase microextraction based on mesoporous carbon coated with silica@iron oxide nanocomposite for preconcentration of Te and Tl in natural water systems
  31. N,N′-Bis[2-hydroxynaphthylidene]/[2-methoxybenzylidene]amino]oxamides and their divalent manganese complexes: Isolation, spectral characterization, morphology, antibacterial and cytotoxicity against leukemia cells
  32. Determination of the content of selected trace elements in Polish commercial fruit juices and health risk assessment
  33. Diorganotin(iv) benzyldithiocarbamate complexes: synthesis, characterization, and thermal and cytotoxicity study
  34. Keratin 17 is induced in prurigo nodularis lesions
  35. Anticancer, antioxidant, and acute toxicity studies of a Saudi polyherbal formulation, PHF5
  36. LaCoO3 perovskite-type catalysts in syngas conversion
  37. Comparative studies of two vegetal extracts from Stokesia laevis and Geranium pratense: polyphenol profile, cytotoxic effect and antiproliferative activity
  38. Fragmentation pattern of certain isatin–indole antiproliferative conjugates with application to identify their in vitro metabolic profiles in rat liver microsomes by liquid chromatography tandem mass spectrometry
  39. Investigation of polyphenol profile, antioxidant activity and hepatoprotective potential of Aconogonon alpinum (All.) Schur roots
  40. Lead discovery of a guanidinyl tryptophan derivative on amyloid cascade inhibition
  41. Physicochemical evaluation of the fruit pulp of Opuntia spp growing in the Mediterranean area under hard climate conditions
  42. Electronic structural properties of amino/hydroxyl functionalized imidazolium-based bromide ionic liquids
  43. New Schiff bases of 2-(quinolin-8-yloxy)acetohydrazide and their Cu(ii), and Zn(ii) metal complexes: their in vitro antimicrobial potentials and in silico physicochemical and pharmacokinetics properties
  44. Treatment of adhesions after Achilles tendon injury using focused ultrasound with targeted bFGF plasmid-loaded cationic microbubbles
  45. Synthesis of orotic acid derivatives and their effects on stem cell proliferation
  46. Chirality of β2-agonists. An overview of pharmacological activity, stereoselective analysis, and synthesis
  47. Fe3O4@urea/HITh-SO3H as an efficient and reusable catalyst for the solvent-free synthesis of 7-aryl-8H-benzo[h]indeno[1,2-b]quinoline-8-one and indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine derivatives
  48. Adsorption kinetic characteristics of molybdenum in yellow-brown soil in response to pH and phosphate
  49. Enhancement of thermal properties of bio-based microcapsules intended for textile applications
  50. Exploring the effect of khat (Catha edulis) chewing on the pharmacokinetics of the antiplatelet drug clopidogrel in rats using the newly developed LC-MS/MS technique
  51. A green strategy for obtaining anthraquinones from Rheum tanguticum by subcritical water
  52. Cadmium (Cd) chloride affects the nutrient uptake and Cd-resistant bacterium reduces the adsorption of Cd in muskmelon plants
  53. Removal of H2S by vermicompost biofilter and analysis on bacterial community
  54. Structural cytotoxicity relationship of 2-phenoxy(thiomethyl)pyridotriazolopyrimidines: Quantum chemical calculations and statistical analysis
  55. A self-breaking supramolecular plugging system as lost circulation material in oilfield
  56. Synthesis, characterization, and pharmacological evaluation of thiourea derivatives
  57. Application of drug–metal ion interaction principle in conductometric determination of imatinib, sorafenib, gefitinib and bosutinib
  58. Synthesis and characterization of a novel chitosan-grafted-polyorthoethylaniline biocomposite and utilization for dye removal from water
  59. Optimisation of urine sample preparation for shotgun proteomics
  60. DFT investigations on arylsulphonyl pyrazole derivatives as potential ligands of selected kinases
  61. Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier
  62. New derivatives of a natural nordentatin
  63. Fluorescence biomarkers of malignant melanoma detectable in urine
  64. Study of the remediation effects of passivation materials on Pb-contaminated soil
  65. Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
  66. Withania frutescens: Chemical characterization, analgesic, anti-inflammatory, and healing activities
  67. Design, synthesis and pharmacological profile of (−)-verbenone hydrazones
  68. Synthesis of magnesium carbonate hydrate from natural talc
  69. Stability-indicating HPLC-DAD assay for simultaneous quantification of hydrocortisone 21 acetate, dexamethasone, and fluocinolone acetonide in cosmetics
  70. A novel lactose biosensor based on electrochemically synthesized 3,4-ethylenedioxythiophene/thiophene (EDOT/Th) copolymer
  71. Citrullus colocynthis (L.) Schrad: Chemical characterization, scavenging and cytotoxic activities
  72. Development and validation of a high performance liquid chromatography/diode array detection method for estrogen determination: Application to residual analysis in meat products
  73. PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
  74. Development of trace analysis for alkyl methanesulfonates in the delgocitinib drug substance using GC-FID and liquid–liquid extraction with ionic liquid
  75. Electrochemical evaluation of the antioxidant capacity of natural compounds on glassy carbon electrode modified with guanine-, polythionine-, and nitrogen-doped graphene
  76. A Dy(iii)–organic framework as a fluorescent probe for highly selective detection of picric acid and treatment activity on human lung cancer cells
  77. A Zn(ii)–organic cage with semirigid ligand for solvent-free cyanosilylation and inhibitory effect on ovarian cancer cell migration and invasion ability via regulating mi-RNA16 expression
  78. Polyphenol content and antioxidant activities of Prunus padus L. and Prunus serotina L. leaves: Electrochemical and spectrophotometric approach and their antimicrobial properties
  79. The combined use of GC, PDSC and FT-IR techniques to characterize fat extracted from commercial complete dry pet food for adult cats
  80. MALDI-TOF MS profiling in the discovery and identification of salivary proteomic patterns of temporomandibular joint disorders
  81. Concentrations of dioxins, furans and dioxin-like PCBs in natural animal feed additives
  82. Structure and some physicochemical and functional properties of water treated under ammonia with low-temperature low-pressure glow plasma of low frequency
  83. Mesoscale nanoparticles encapsulated with emodin for targeting antifibrosis in animal models
  84. Amine-functionalized magnetic activated carbon as an adsorbent for preconcentration and determination of acidic drugs in environmental water samples using HPLC-DAD
  85. Antioxidant activity as a response to cadmium pollution in three durum wheat genotypes differing in salt-tolerance
  86. A promising naphthoquinone [8-hydroxy-2-(2-thienylcarbonyl)naphtho[2,3-b]thiophene-4,9-dione] exerts anti-colorectal cancer activity through ferroptosis and inhibition of MAPK signaling pathway based on RNA sequencing
  87. Synthesis and efficacy of herbicidal ionic liquids with chlorsulfuron as the anion
  88. Effect of isovalent substitution on the crystal structure and properties of two-slab indates BaLa2−xSmxIn2O7
  89. Synthesis, spectral and thermo-kinetics explorations of Schiff-base derived metal complexes
  90. An improved reduction method for phase stability testing in the single-phase region
  91. Comparative analysis of chemical composition of some commercially important fishes with an emphasis on various Malaysian diets
  92. Development of a solventless stir bar sorptive extraction/thermal desorption large volume injection capillary gas chromatographic-mass spectrometric method for ultra-trace determination of pyrethroids pesticides in river and tap water samples
  93. A turbidity sensor development based on NL-PI observers: Experimental application to the control of a Sinaloa’s River Spirulina maxima cultivation
  94. Deep desulfurization of sintering flue gas in iron and steel works based on low-temperature oxidation
  95. Investigations of metallic elements and phenolics in Chinese medicinal plants
  96. Influence of site-classification approach on geochemical background values
  97. Effects of ageing on the surface characteristics and Cu(ii) adsorption behaviour of rice husk biochar in soil
  98. Adsorption and sugarcane-bagasse-derived activated carbon-based mitigation of 1-[2-(2-chloroethoxy)phenyl]sulfonyl-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl) urea-contaminated soils
  99. Antimicrobial and antifungal activities of bifunctional cooper(ii) complexes with non-steroidal anti-inflammatory drugs, flufenamic, mefenamic and tolfenamic acids and 1,10-phenanthroline
  100. Application of selenium and silicon to alleviate short-term drought stress in French marigold (Tagetes patula L.) as a model plant species
  101. Screening and analysis of xanthine oxidase inhibitors in jute leaves and their protective effects against hydrogen peroxide-induced oxidative stress in cells
  102. Synthesis and physicochemical studies of a series of mixed-ligand transition metal complexes and their molecular docking investigations against Coronavirus main protease
  103. A study of in vitro metabolism and cytotoxicity of mephedrone and methoxetamine in human and pig liver models using GC/MS and LC/MS analyses
  104. A new phenyl alkyl ester and a new combretin triterpene derivative from Combretum fragrans F. Hoffm (Combretaceae) and antiproliferative activity
  105. Erratum
  106. Erratum to: A one-step incubation ELISA kit for rapid determination of dibutyl phthalate in water, beverage and liquor
  107. Review Articles
  108. Sinoporphyrin sodium, a novel sensitizer for photodynamic and sonodynamic therapy
  109. Natural products isolated from Casimiroa
  110. Plant description, phytochemical constituents and bioactivities of Syzygium genus: A review
  111. Evaluation of elastomeric heat shielding materials as insulators for solid propellant rocket motors: A short review
  112. Special Issue on Applied Biochemistry and Biotechnology 2019
  113. An overview of Monascus fermentation processes for monacolin K production
  114. Study on online soft sensor method of total sugar content in chlorotetracycline fermentation tank
  115. Studies on the Anti-Gouty Arthritis and Anti-hyperuricemia Properties of Astilbin in Animal Models
  116. Effects of organic fertilizer on water use, photosynthetic characteristics, and fruit quality of pear jujube in northern Shaanxi
  117. Characteristics of the root exudate release system of typical plants in plateau lakeside wetland under phosphorus stress conditions
  118. Characterization of soil water by the means of hydrogen and oxygen isotope ratio at dry-wet season under different soil layers in the dry-hot valley of Jinsha River
  119. Composition and diurnal variation of floral scent emission in Rosa rugosa Thunb. and Tulipa gesneriana L.
  120. Preparation of a novel ginkgolide B niosomal composite drug
  121. The degradation, biodegradability and toxicity evaluation of sulfamethazine antibiotics by gamma radiation
  122. Special issue on Monitoring, Risk Assessment and Sustainable Management for the Exposure to Environmental Toxins
  123. Insight into the cadmium and zinc binding potential of humic acids derived from composts by EEM spectra combined with PARAFAC analysis
  124. Source apportionment of soil contamination based on multivariate receptor and robust geostatistics in a typical rural–urban area, Wuhan city, middle China
  125. Special Issue on 13th JCC 2018
  126. The Role of H2C2O4 and Na2CO3 as Precipitating Agents on The Physichochemical Properties and Photocatalytic Activity of Bismuth Oxide
  127. Preparation of magnetite-silica–cetyltrimethylammonium for phenol removal based on adsolubilization
  128. Topical Issue on Agriculture
  129. Size-dependent growth kinetics of struvite crystals in wastewater with calcium ions
  130. The effect of silica-calcite sedimentary rock contained in the chicken broiler diet on the overall quality of chicken muscles
  131. Physicochemical properties of selected herbicidal products containing nicosulfuron as an active ingredient
  132. Lycopene in tomatoes and tomato products
  133. Fluorescence in the assessment of the share of a key component in the mixing of feed
  134. Sulfur application alleviates chromium stress in maize and wheat
  135. Effectiveness of removal of sulphur compounds from the air after 3 years of biofiltration with a mixture of compost soil, peat, coconut fibre and oak bark
  136. Special Issue on the 4th Green Chemistry 2018
  137. Study and fire test of banana fibre reinforced composites with flame retardance properties
  138. Special Issue on the International conference CosCI 2018
  139. Disintegration, In vitro Dissolution, and Drug Release Kinetics Profiles of k-Carrageenan-based Nutraceutical Hard-shell Capsules Containing Salicylamide
  140. Synthesis of amorphous aluminosilicate from impure Indonesian kaolin
  141. Special Issue on the International Conf on Science, Applied Science, Teaching and Education 2019
  142. Functionalization of Congo red dye as a light harvester on solar cell
  143. The effect of nitrite food preservatives added to se’i meat on the expression of wild-type p53 protein
  144. Biocompatibility and osteoconductivity of scaffold porous composite collagen–hydroxyapatite based coral for bone regeneration
  145. Special Issue on the Joint Science Congress of Materials and Polymers (ISCMP 2019)
  146. Effect of natural boron mineral use on the essential oil ratio and components of Musk Sage (Salvia sclarea L.)
  147. A theoretical and experimental study of the adsorptive removal of hexavalent chromium ions using graphene oxide as an adsorbent
  148. A study on the bacterial adhesion of Streptococcus mutans in various dental ceramics: In vitro study
  149. Corrosion study of copper in aqueous sulfuric acid solution in the presence of (2E,5E)-2,5-dibenzylidenecyclopentanone and (2E,5E)-bis[(4-dimethylamino)benzylidene]cyclopentanone: Experimental and theoretical study
  150. Special Issue on Chemistry Today for Tomorrow 2019
  151. Diabetes mellitus type 2: Exploratory data analysis based on clinical reading
  152. Multivariate analysis for the classification of copper–lead and copper–zinc glasses
  153. Special Issue on Advances in Chemistry and Polymers
  154. The spatial and temporal distribution of cationic and anionic radicals in early embryo implantation
  155. Special Issue on 3rd IC3PE 2020
  156. Magnetic iron oxide/clay nanocomposites for adsorption and catalytic oxidation in water treatment applications
  157. Special Issue on IC3PE 2018/2019 Conference
  158. Exergy analysis of conventional and hydrothermal liquefaction–esterification processes of microalgae for biodiesel production
  159. Advancing biodiesel production from microalgae Spirulina sp. by a simultaneous extraction–transesterification process using palm oil as a co-solvent of methanol
  160. Topical Issue on Applications of Mathematics in Chemistry
  161. Omega and the related counting polynomials of some chemical structures
  162. M-polynomial and topological indices of zigzag edge coronoid fused by starphene
Downloaded on 8.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/chem-2020-0103/html?lang=en
Scroll to top button